---
figid: PMC7846970__cs-135-cs20200480-g3
figtitle: 'ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated
  vascular disease'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7846970
filename: cs-135-cs20200480-g3.jpg
figlink: pmc/articles/PMC7846970/figure/F3/
number: F3
caption: In endothelial cells, Ang-(1-7) activates eNOS via AKT to produce nitric
  oxide. Ang-(1-7) also stimulates production of vasodilators such as prostacyclin
  (PGI2) and prostaglandin (PGE2) via enhancement of phospholipase A2 (PLA2) activity
  and arachidonic acid (AA) release. Ang-(1-7) via Mas1 counter-regulates Ang II effects
  by increasing expression of anti-ageing protein klotho which consequently activates
  Nrf2/HO-1 pathway and activation of c-Src, ERK1/2 and NADPH oxidase (Nox) by enhancing
  SHP-2 phosphorylation. In smooth muscle cells, Ang-(1-7) via Mas1 receptor opposes
  Ang II-induced contraction and oxidative stress by attenuating RhoA/ROCK2 signalling,
  PLC and NADPH activation. Ang-(1-7) also suppresses Ang II-induced proliferation
  and inflammation by inhibiting MAPKs (ERK1/2, p38MAPK and JNK), MMP-8 and NFκB signalling.
  AKT, serine threonine specific protein kinase; Ang II, angiotensin II; Ang-(1-7),
  angiotensin-(1-7); AT1R, angiotensin two type one receptor; ERK1/2, extracellular
  regulated kinase one and two; HO-1, haem oxygenase one; JNK, c-Jun N-terminal kinases;
  MAPK, mitogen-activated protein kinase; Mas1, mas1 receptor; MMP-8, matrix metalloproteinase
  8; NADPH, nicotinamide adenine dinucleotide phosphate; NFkB, nuclear factor kappa
  B; Nrf2, nuclear factor erythroid 2-related factor 2; PLC, phospholipase C; RhoA/ROCK2,
  RAAS homolog family member A/Rho associated coiled-coil containing protein kinase
  2; ROS, reactive oxygen species; SHP-2, small heterodimer partner 2.
papertitle: 'ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated
  vascular disease.'
reftext: Jithin Kuriakose, et al. Clin Sci (Lond). 2021 Jan;135(2):387-407.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9683595
figid_alias: PMC7846970__F3
figtype: Figure
redirect_from: /figures/PMC7846970__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7846970__cs-135-cs20200480-g3.html
  '@type': Dataset
  description: In endothelial cells, Ang-(1-7) activates eNOS via AKT to produce nitric
    oxide. Ang-(1-7) also stimulates production of vasodilators such as prostacyclin
    (PGI2) and prostaglandin (PGE2) via enhancement of phospholipase A2 (PLA2) activity
    and arachidonic acid (AA) release. Ang-(1-7) via Mas1 counter-regulates Ang II
    effects by increasing expression of anti-ageing protein klotho which consequently
    activates Nrf2/HO-1 pathway and activation of c-Src, ERK1/2 and NADPH oxidase
    (Nox) by enhancing SHP-2 phosphorylation. In smooth muscle cells, Ang-(1-7) via
    Mas1 receptor opposes Ang II-induced contraction and oxidative stress by attenuating
    RhoA/ROCK2 signalling, PLC and NADPH activation. Ang-(1-7) also suppresses Ang
    II-induced proliferation and inflammation by inhibiting MAPKs (ERK1/2, p38MAPK
    and JNK), MMP-8 and NFκB signalling. AKT, serine threonine specific protein kinase;
    Ang II, angiotensin II; Ang-(1-7), angiotensin-(1-7); AT1R, angiotensin two type
    one receptor; ERK1/2, extracellular regulated kinase one and two; HO-1, haem oxygenase
    one; JNK, c-Jun N-terminal kinases; MAPK, mitogen-activated protein kinase; Mas1,
    mas1 receptor; MMP-8, matrix metalloproteinase 8; NADPH, nicotinamide adenine
    dinucleotide phosphate; NFkB, nuclear factor kappa B; Nrf2, nuclear factor erythroid
    2-related factor 2; PLC, phospholipase C; RhoA/ROCK2, RAAS homolog family member
    A/Rho associated coiled-coil containing protein kinase 2; ROS, reactive oxygen
    species; SHP-2, small heterodimer partner 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Taf12
  - Nlp
  - und
  - tral
  - glo
  - Nox
  - sta
  - mip40
  - p47
  - prtp
  - CG42383
  - alpha-Man-Ia
  - csw
  - Dif
  - dl
  - Rel
  - Src64B
  - Rho1
  - Rok
  - CG42237
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - aa
  - rl
  - Akt
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - CG9701
  - bsk
  - Mlc1
  - Mlc2
  - Nplp1
  - Pgi
  - norpA
  - sl
  - Plc21C
  - Ho
  - ANGPT2
  - VPS51
  - DYNC1H1
  - CHP1
  - PHB2
  - CD33
  - STXBP1
  - IL9
  - RPSA
  - MAPK1
  - PSMD7
  - TP63
  - ARHGEF2
  - RABEPK
  - LANCL1
  - EBNA1BP2
  - BRMS1L
  - ARMH1
  - H3P28
  - ING1
  - PLEK
  - CLEC11A
  - AKAP13
  - NSFL1C
  - H3P37
  - MAS1
  - PMPCB
  - AGTR1
  - PTPN11
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SRC
  - RHOA
  - ROCK2
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - CRK
  - MAPK14
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - BGN
  - GPI
  - PGPEP1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - NOS3
  - ENO4
  - MMP8
  - HMOX1
  - NIT2
  - PGE2
---
